Karen S. Lynch is CEO & President at CVS HEALTH Corp (CVS). They have made 5 open-market trades across 2 companies since 2016, most recently 2026-05-20.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $977K since 2023, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CVS | BUY | 2023-05-03 | 2023-05-05 | $69.75 | $977K | -1.4% | +0.4% | +5.5% |
| CVS | SELL | 2019-11-18 | 2019-11-20 | $75.00 | $6.0M | -0.2% | -0.4% | -3.8% |
| AET | SELL | 2017-09-18 | 2017-09-20 | $161.91 | $4.9M | +4.0% | +4.3% | +16.0% |
| AET | SELL | 2017-06-07 | 2017-06-09 | $149.72 | $1.2M | +1.8% | +3.1% | +7.2% |
| AET | SELL | 2016-11-11 | 2016-11-15 | $119.55 | $5.4M | +4.3% | +1.9% | -0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.